BridgeMD
New treatment option for Diabetes Mellitus Type 2
Official title The Effect of Propolis Administration on Cholesterol Level in Diabetic Type 2 Patients
ClinicalTrials.gov ID: NCT06903546
What this study is testing
What is Propolis drops?
Propolis drops is an investigational medicine, given as an once-daily, being studied as a potential treatment for diabetes mellitus type 2.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to learn if propolis administration works to change the level of Low Density Lipoprotein (LDL) and High Density Lipoprotein cholesterol (HDL) in diabetic type 2 patients. The main questions it aims to answer are: \- Is giving 1 drops/ 10kg/ times, twice daily for 8 weeks will change the level of LDL and HDL level in diabetic type 2 patients compared to placebo?
- Phase 4: studies an already-approved treatment
- You might receive a placebo (an inactive treatment) instead of the study drug. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 35 to 59
You may be able to join if
- Controlled Diabetes Mellitus type 2 with HbA1c \<7.5%
- BMI 23-35 kg/m2
- On anti-cholesterol therapy
You likely can't join if
- Using injection therapy (insulin or GLP-1 RA)
- History of bees product allergy
- Active smoker
- Consuming alcohol
- Altered liver (ALT\>35 IU/L) and kidney (eGFR\<90 mL/min) function
- Pregnant and breastfeeding women
See the full eligibility criteria
- Controlled Diabetes Mellitus type 2 with HbA1c \<7.5%
- BMI 23-35 kg/m2
- On anti-cholesterol therapy
- Using injection therapy (insulin or GLP-1 RA)
- History of bees product allergy
- Active smoker
- Consuming alcohol
- Altered liver (ALT\>35 IU/L) and kidney (eGFR\<90 mL/min) function
- Pregnant and breastfeeding women
- History of cardiovascular disease (heart attack, stroke)
The study team makes the final eligibility decision.
Where it's taking place
- Jakarta, Indonesia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 35 years to 59 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Jakarta, Indonesia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.